Shares of BioDelivery Sciences International (BDSI) soared 22% in active premarket trade after the company and its partner, Endo Pharmaceuticals, said a late-stage trial of its severe pain treatment met its primary efficacy endpoint. At 10:30 AM the stock is up 15.51 % form Fridays close to $13.87 and touched a new high briefly at $14.38. Volume […]
↧
